Reduced GSK-3β expression in BC leads to upregulation of GPX4 and downregulation of arachidonic acid 15-lipoxygenase, resulting in decreased levels of ROS and malondialdehyde (MDA). This evidence concerns the gene GPX4 and breast cancer.